# Long Acting Buprenorphine Injection Compared to Sublingual Buprenorphine/Naloxone Films

> **NCT03744663** · PHASE2 · WITHDRAWN · sponsor: **Wake Forest University Health Sciences**

## Conditions studied

- Opioid Use

## Interventions

- **DRUG:** Suboxone® SL
- **DRUG:** Sublocade®

## Key facts

- **NCT ID:** NCT03744663
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-06
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding for uninsured subjects could not be realized and staffing after COVID hit was also a problem.
- **Last updated:** 2022-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03744663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03744663, "Long Acting Buprenorphine Injection Compared to Sublingual Buprenorphine/Naloxone Films". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03744663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*